InMed Pharmaceuticals Inc. (INM)
NCM · Common · CUSIP 45782T105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for INM and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45782T105
Market Cap
Micro Cap
Previous Symbol
IMLFF (changed 11/10/2020)
Business: InMed Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that specializes in the discovery and development of novel, cannabinoid-based therapeutics for the treatment of diseases with high unmet medical need.

Company Contact

CEO
Eric A. Adams
CFO
Netta Jagpal
Headquarters
Suite 310 - 815 W. Hastings Street, Vancouver, B.C. V6C 1B4, Canada
Phone
604-669-7207
Investor Relations
Colin Clancy · 604-416-0999 · ir@inmedpharma.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »
SEDAR+ Filings
Go to SEDAR+ »